I kind of hope you would think this way. Because the ruse has to happen when everyone has finally given up. This is not going to be a gradual takeoff. If we can have 20 middle of the night take downs, what happens when they take the constraints off? The next middle of the night event, is going to be one in the other direction. Too many of the experts are now shifting their narrative on manipulation. It seems that they do not want to look stupid.
Date VolShorted High Low Close ShortVol RegularVol
Jul 20 25.36% 0.36 0.29 0.30 284,355 1,121,053
Jul 17 29.14% 0.38 0.34 0.35 230,605 791,342
Jul 16 36.16% 0.38 0.34 0.37 288,593 798,128
Jul 15 20.01% 0.39 0.33 0.33 105,291 526,296
Jul 14 15.28% 0.49 0.49 0.49 48,525 317,475
He post topics, so he can reply to. All the boards I have left roryrae with, are doing the same thing. Trying desperately to conjure up a discussion. The problem, is that old roryrae has nothing of substance. Ask the replies to ZAM to take a simple test. Bet that doesn't happen.
That is all that has traded on Sci-vac counting today's volume, since this opened. That is very small compared to the float. Why would any group accept 33% less for shares? Are the shorts over playing their hand here?
Easy answer. They created $144M of market cap out of thin air. Unlike COCP the insiders wanted no part of preferred shares. Earning season can #$%$ the markets and biotech has enjoyed the easy money, maybe the bubble is over? It's not this easy to make money and when the ride stops, the reality begins. Frost probably took to long getting this deal finished and the confusion on shares, didn't help.
I didn't post this to make you feel good. At $1,500 you can trade out, allow the consolidation and then jump back in for the ride to $2,000 an ounce. Pershing will go to the strongest bidder. I would say something around $50 a share. That leach pad is the golden ticket, when this takes off. Discovery is at the lowest point, so demand for what is available to get into, will demand the highest price and Frost and Barry are the best at getting FULL value. Can anyone deny that.
I see a spike to $1,500, then a pull back. The next leg up will send it to $2K. They are setting this up for a huge bounce and they know most longs are just letting go. Most will be caught off guard on how fast this will turn. With the shares falling into strong hands, they can get you to chase, but never catch up.
Our time is fast approaching. Look when the pollocks start showing up on message boards, you have to know you are very close.
Actually, I think you are k9. Interesting that you bring up CL. I really don't care. I just pointing out how these boards work.
Whatever you say rory. Been doing the dance with you so long, that I can see the pattern 10 minutes, before you conjure it up. I knew it was just a matter of time, before you started the mining debate. Lucky for us mining shares, were the only ones profitable at this time. Ironic how the biotech guys are the ones losing money here.
Guess we can make this board a zoo. Your choice, but watch out what you wish for.
I think it's time to ask the numerous id's to start showing things are real. It seems that there is always a certain element that has a agenda to discredit. You can hide it only so long. How many Id's this time will you need?
I tried pointing this out last week. But got met with the alpha dogs, trying to show us they have a clue. Before this deal got finalized the street gave it a value of $114M.
Today as the dust clears, we have $238M in combined value. But most of that was traded from us to the insiders at Sci-vac. We actually have seen our market cap fall from $114M to $85.68M. Now watch one of those alpha dogs, immediately try and discredit the math. Last week they came up short on this and so, I'm confident that I can defend the number. I'm still happy, but not as happy as last week.
We all looked smarter last week. Not so much this week. The post market value now sits at .36. Both sides taking some value away. One announcement can change things fast.
We all have views of our investments. We all like to think we have a clue. The sad part with dbtunr is, he will sell his soul, in hopes his view is the correct one. It's alright to disagree, however dbtunr will take it beyond that. Invent a narrative out of thin air. I like to win, but not at losing my integrity to do it.
Dbtunr likes to dish it out, he's not so good at taking it. He likes to pry into your investments, but he has issue's when you pay him back. When he looks really stupid, he invents things out of thin air.
The worst part, he has no shame in what he posts. He posts in retaliation mode. He digs for a small piece of info and then uses it out of context. I try and give him a taste of his medicine. If he has an actual working brain, then maybe he learns something about himself. I think old dbtunr has been humbled. Something we could not show him, the markets have done that for us.
I look at this stock and a scratch my head. Clever how insiders dangle a little carrot, while they take advantage of those cheap shares they were given. This would be $7 stock without the dividend. Others should take a page from this playbook. GL with dbtunr, he's your problem now.
Interesting things to note. Guardum Pharma got bought out by Pharmsynthez (a Russian company). Isn't this the same company that SCi-vac got the Vac-B from? Small world? Is Frost setting up a Russian copy of what TEVA does?
Last quaarter to compare with:
Cash on hand $1.343M
Accts Pay 1.553M
This looks like one of the easiest IS to read through. Hopefully they add some decent revenues. Think we need to see 10-20% growth to get some respect from the markets.
Dr. Lockshin has as served as Chief Executive Officer of SciVac since September 2014. Since March 2014, Dr. Lockshin has served as the Vice President of Research and Operations of Xenetic Biosciences, Inc., a biopharmaceutical company focused on developing biologic drugs and novel oncology therapeutics. Since May 2013, Dr. Lockshin has served as the President and CEO of Guardum Pharmaceuticals, LLC, a private pharmaceutical company. From October 2011 to February 2013, Dr. Lockshin served as Vice President of Corporate R&D Initiatives for OPKO Health, Inc. (“OPKO”), a multi-national biopharmaceutical and diagnostics company, developing a range of solutions to diagnose, treat and prevent various conditions, including point-of-care tests, laboratory developed tests, and proprietary pharmaceuticals and vaccines (NYSE: OPK), following which he assumed the position of consultant to OPKO until December 2013. Since April 2013, Dr. Lockshin has served on the board of directors of RXi Pharmaceuticals Corp. (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics. From March 2011 until December 2013, Dr. Lockshin served as a member of the board of directors for ChromaDex, Inc., a natural products company engaged in the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. From October 2009 to September 2012, Dr. Lockshin served as a member of the board of directors for Sorrento Therapeutics, Inc., a development-stage biopharmaceutical company. Since April 2004, Dr. Lockshin has also served as a member of the board of directors of the Ruth K. Broad Biomedical Research Foundation. The foundation is a Duke University Support Corporation that supports basic research related to Alzheimer’s disease and neurodegeneration via intramural, extramural and international grants. Since 2003, Dr. Lockshin has worked as an independent consultant, focusing on small private companies in the healthcare, biotechnology and securit
He doesn't like the taste of his medicine. Bashes and pumps and when it backfires on him, he needs to ignore. He was bragging about having one of his best years, then he spoiled it all by investing in RVM. I figure he has given back 15 years of profits in just a few weeks.
Dbtunr thinks he's interesting. Some of us believe he's a freak show. His HL shares are seeing new lows. He's down over 75%. He had to claim he sold it, but we know better. Nice call MR. Interesting.